The Medicines and Healthcare products Regulatory Agency (MHRA) and manufacturers' Summaries of Product Characteristics (SmPCs) consistently advise against using GLP-1 receptor agonists whilst breastfeeding due to insufficient data on excretion into human breast milk and potential effects on nursing infants
Medications and supplements: differences between ASD groups Medication and supplements were compared across groups (Table 2)
The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration
Begin by reviewing your medical history and ensuring your healthcare provider is fully aware of all medications, supplements, and health conditions you have
most cases appear to be sporadic, in which both genetic and environmental risk factors play a role 7 , while a small proportion arise from monogenic mutations
doi: 10.34067/kid.0001002022 151